Frontlight ResearchEarly access
Trial site
Institut Fuer Praeventive Medizin & Klinische Forschung GbR
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Obesity2 trials
- Rheumatoid arthritis2 trials
- Ankylosing spondylitis1 trial
- Familial hypercholesterolaemia1 trial
- Graves' disease1 trial
- High blood pressure1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 43 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- argenx1 trial
- AstraZeneca1 trial
- AstraZeneca AB1 trial
- Boehringer Ingelheim1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Obesity2 recruiting
- Graves' disease1 recruiting
- High blood pressure1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026